Fuji Pharma Co., Ltd. (TYO:4554)

Market Cap	55.33B +60.2%
Revenue (ttm)	54.57B +12.8%
Net Income	2.33B -47.0%
EPS	95.47 -47.2%
Shares Out	24.47M
PE Ratio	23.68
Forward PE	15.41
Dividend	47.00 (2.08%)
Ex-Dividend Date	Mar 30, 2026

Volume	194,400
Average Volume	296,690
Open	2,303.00
Previous Close	2,261.00
Day's Range	2,300.00 - 2,394.00
52-Week Range	1,180.00 - 2,446.00
Beta	0.37
RSI	63.32
Earnings Date	Feb 5, 2026

About Fuji Pharma

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 1,760
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4554

Financial Performance

In fiscal year 2025, Fuji Pharma's revenue was 51.68 billion, an increase of 12.01% compared to the previous year's 46.14 billion. Earnings were 3.00 billion, a decrease of -51.19%.